Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria to Sweden-based Atlas Antibodies in a deal that values Evitria at more than EUR 200m.
Fund has made four platform investments and backs European digital and technology-based companies
Toni Gillespie joins as chief of talent, while Elisabetta Ricci joins as chief of staff
GP backed the business – then called Ryds Bilglas – via Nordic Capital VIII in 2018
Auction of the Italian producer of natural flavours and ingredients is expected to launch in early 2022